But arguably worse than the screens themselves is the hodgepodge of icons premium carmakers now seem to be obsessed with. I want to avoid sounding like an old fart here. I totally understand that the ...

Advanced Micro Devices has emerged as a worthy competitor and is attracting many of Nvidia's top customers. AMD CEO Lisa Su just gave investors a fresh look at the company's newest AI chips.

An immunotherapy approach to treating advanced Hodgkin lymphoma may drastically increase patients’ chances of survival, including those as young as 12, according to a new clinical trial.

The U.S. Dept. of Energy (DOE) announced six companies have successfully bid to provide deconversion services for high-assay low-enriched uranium (HALEU) fuel to support advanced nuclear reactors.

Oct. 18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa). This new option is designed to help people ...

Vyalev combines foscarbidopa, a prodrug of carbidopa, and foslevodopa, a prodrug of levodopa, into a solution for continuous subcutaneous 24-hour infusion. The Food and Drug Administration (FDA ...

(RTTNews) - Honeywell (HON) announced a plan to spin off its Advanced Materials business into a U.S. publicly traded company, which is targeted to be completed by the end of 2025 or early 2026.

Biden Admin to Provide $750 Million to North Carolina-Based Wolfspeed for Advanced Computer Chips WASHINGTON (AP) — The Biden-Harris administration announced plans Tuesday to provide up to $750 ...

Fans say the success of "Terrifier 3" has cemented its lead character, the demonic, mute serial killer Art the Clown, as a horror icon. Played by David Howard Thornton, Art returns in "Terrifier 3 ...

An icon of a desk calendar. An icon of a circle with a diagonal line across. An icon of a block arrow pointing to the right. An icon of a paper envelope. An icon of the Facebook "f" mark.

Itovebi is approved for PIK3CA-mutated, HR-positive, HER2-negative advanced breast cancer after adjuvant endocrine therapy recurrence. The INAVO120 trial showed Itovebi improved progression-free ...